Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Carbinoxamine maleate |
Is a |
False |
Carbinoxamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbinoxamine measurement |
Component |
True |
Carbinoxamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5mL/15mg/5mL/60mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbinoxamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 2mg/1mL/4mg/1mL/25mg/1mL liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbinoxamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 2mg/1mL/4mg/1mL/15mg/1mL liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbinoxamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbinoxamine maleate+pseudoephedrine hydrochloride 4mg/5mL/60mg/5mL liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbinoxamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbinoxamine maleate+pseudoephedrine hydrochloride 2mg/1mL/15mg/1mL liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbinoxamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbinoxamine maleate+pseudoephedrine hydrochloride 2mg/1mL/25mg/1mL liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbinoxamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbinoxamine maleate+pseudoephedrine hydrochloride 2mg/5mL/30mg/5mL liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbinoxamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely carbinoxamine maleate 4 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbinoxamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbinoxamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbinoxamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbinoxamine maleate+pseudoephedrine hydrochloride 8mg/120mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbinoxamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5mL/12.5mg/5mL/60mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbinoxamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 1mg/1mL/4mg/1mL/15mg/1mL drop |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbinoxamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbinoxamine maleate+pseudoephedrine hydrochloride 1mg/1mL/15mg/1mL drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbinoxamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbinoxamine (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carbinoxamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbinoxamine 4 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbinoxamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbinoxamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely carbinoxamine 4 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbinoxamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbinoxamine 4 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Carbinoxamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing carbinoxamine and dextromethorphan and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carbinoxamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carbinoxamine maleate |
Is modification of (attribute) |
True |
Carbinoxamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbinoxamine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carbinoxamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbinoxamine 4 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Carbinoxamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing carbinoxamine and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carbinoxamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing carbinoxamine and pseudoephedrine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carbinoxamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only carbinoxamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carbinoxamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carbinoxamine and dextromethorphan and pseudoephedrine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carbinoxamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carbinoxamine and pseudoephedrine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carbinoxamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only carbinoxamine and pseudoephedrine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carbinoxamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carbinoxamine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carbinoxamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carbinoxamine and dextromethorphan and pseudoephedrine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carbinoxamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing carbinoxamine and dextromethorphan and pseudoephedrine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carbinoxamine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |